- World rank, all time
- #18,667 of 42,892
- Rank in Austria
- #126 of 287
- Research works
- 185 ▼ 14% vs 2013–17
- Citations
- 8.2k 44.5 per fractional work
- Top-10% rate
- 15.5% record average 16.5%
- Open access
- 58% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.8×. Every wedge is a field page.
- Immunology and Microbiology 6.8×
- Pharmacology, Toxicology and Pharmaceutics 5.5×
- Biochemistry, Genetics and Molecular Biology 5.5×
- Chemistry 3.9×
- Chemical Engineering 3.4×
- Veterinary 3.0×
- Medicine 1.9×
- Agricultural and Biological Sciences 1.2×
- Nursing 0.8×
- Neuroscience 0.7×
- Earth and Planetary Sciences 0.5×
- Engineering 0.4×
- Materials Science 0.3×
- Computer Science 0.2×
- Environmental Science 0.2×
- Arts and Humanities 0.1×
Which keywords describe research at Tyrolean Cancer Research Institute?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Immunity, Cancer Therapy, Inflammation, Tumor Microenvironment, Gene Expression, Mutation and Apoptosis.
- Mutation
- Immune Response
- Tumor Microenvironment
- Cancer Therapy
- Inflammation
- Cancer
- Immunity
- Gene Expression
- Apoptosis
- Immunotherapy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 10 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 10 words, with their numbers
- Cancer4▲ 10.0×26 topics
- Inflammation2▲ 4.0×12 topics
- Immunity2▲ 18×7 topics
- Cancer Therapy2▲ 11×8 topics
- Gene Expression2▲ 9.0×6 topics
- Tumor Microenvironment2▲ 13×6 topics
- Apoptosis1▲ 13×8 topics
- Immune Response1▲ 6.9×4 topics
- Immunotherapy1▲ 5.6×11 topics
- Mutation1▲ 22×4 topics
Which research topics does Tyrolean Cancer Research Institute publish most on?
By volume in 2022–2025: Immune cells in cancer, Advanced Chemical Sensor Technologies, Single-cell and spatial transcriptomics and Cancer, Hypoxia, and Metabolism.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Immune cells in cancer Immunology 1 works
- 2 Advanced Chemical Sensor Technologies Biomedical Engineering 1 works
- 3 Single-cell and spatial transcriptomics Molecular Biology 1 works
- 4 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
- 5 Chronic Myeloid Leukemia Treatments Hematology 1 works
- 6 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 7 Melanoma and MAPK Pathways Molecular Biology 1 works
- 8 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
- 9 Cancer Cells and Metastasis Oncology 0 works
- 10 Metal complexes synthesis and properties Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Tyrolean Cancer Research Institute's research output changed?
Output in 2018–2022 was 14% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Innsbruck
- Universität Innsbruck
- Innsbruck Medical University
- University Clinic of Traumatology
- University Hospital Innsbruck
- Management Center Innsbruck
- Tirol Kliniken
- Institute for Quantum Optics and Quantum Information Innsbruck
- MED-EL (Austria)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.